NO960123D0 - Fluorescerende lateks inneholdende to fluorkrom, fremgangsmåte for fremstilling av den og anvendelse av denne - Google Patents

Fluorescerende lateks inneholdende to fluorkrom, fremgangsmåte for fremstilling av den og anvendelse av denne

Info

Publication number
NO960123D0
NO960123D0 NO960123A NO960123A NO960123D0 NO 960123 D0 NO960123 D0 NO 960123D0 NO 960123 A NO960123 A NO 960123A NO 960123 A NO960123 A NO 960123A NO 960123 D0 NO960123 D0 NO 960123D0
Authority
NO
Norway
Prior art keywords
pct
fluorochrome
fluorochromes
preparation
fluorescent latex
Prior art date
Application number
NO960123A
Other languages
English (en)
Other versions
NO960123L (no
NO308253B1 (no
Inventor
Sophie Vaslin
Joel Richard
Dominique Teychenne
Frederic Ricchiero
Dan Lerner
Original Assignee
Prolabo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolabo Sa filed Critical Prolabo Sa
Publication of NO960123D0 publication Critical patent/NO960123D0/no
Publication of NO960123L publication Critical patent/NO960123L/no
Publication of NO308253B1 publication Critical patent/NO308253B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO960123A 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne NO308253B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9308573A FR2707658B1 (fr) 1993-07-12 1993-07-12 Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie.
PCT/FR1994/000867 WO1995002635A1 (fr) 1993-07-12 1994-07-11 Latex fluorescent comportant au moins deux fluorochromes, procede d'obtention et application

Publications (3)

Publication Number Publication Date
NO960123D0 true NO960123D0 (no) 1996-01-11
NO960123L NO960123L (no) 1996-03-12
NO308253B1 NO308253B1 (no) 2000-08-21

Family

ID=9449186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960123A NO308253B1 (no) 1993-07-12 1996-01-11 Fluorescerende lateks inneholdende to fluorkrom, fremgangsmÕte for fremstilling av den og anvendelse av denne

Country Status (10)

Country Link
US (1) US5716855A (no)
EP (1) EP0712426B1 (no)
JP (1) JPH09504041A (no)
CA (1) CA2167072C (no)
DE (1) DE69403663T2 (no)
DK (1) DK0712426T3 (no)
ES (1) ES2104405T3 (no)
FR (1) FR2707658B1 (no)
NO (1) NO308253B1 (no)
WO (1) WO1995002635A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5578498A (en) * 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
JP3338616B2 (ja) * 1996-09-05 2002-10-28 富士通株式会社 蛍光体層の形成方法及び蛍光体ペースト
WO1999019515A1 (en) * 1997-10-14 1999-04-22 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same
AU2679899A (en) 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
WO2000014545A1 (en) * 1998-09-03 2000-03-16 Trellis Bioinformatics, Inc. Multihued labels
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
CA2531125A1 (en) * 2003-07-02 2005-01-13 Perkinelmer Las, Inc. Scintillator composition for a radioassay, and method for its use
US7407816B2 (en) * 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
WO2006027738A1 (en) * 2004-09-10 2006-03-16 Philips Intellectual Property & Standards Gmbh Compounds and methods for combined optical-ultrasound imaging
US7507588B2 (en) * 2005-04-20 2009-03-24 Becton, Dickinson And Company Multiplex microparticle system
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
NO20053373D0 (no) 2005-07-11 2005-07-11 Rikshospitalet Radiumhospitale Multicolored Particles.
KR101796796B1 (ko) 2009-02-09 2017-11-10 메르크 파텐트 게엠베하 전기영동 디스플레이용 착색 입자
EP2393850A1 (en) 2009-02-09 2011-12-14 Merck Patent GmbH Coloured particles for electrophoretic displays
WO2010089058A1 (en) 2009-02-09 2010-08-12 Merck Patent Gmbh, Coloured particles for electrophoretic displays
US8593719B2 (en) 2009-02-09 2013-11-26 Merck Patent Gmbh Particles for electrophoretic displays
GB2475226A (en) * 2009-11-03 2011-05-18 Genetic Analysis As Universal Prokaryote 16S ribosome PCR primer pair
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
GB201021397D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Diagnosis of Crohn's disease
GB201102693D0 (en) 2011-02-16 2011-03-30 Genetic Analysis As Method for identifying neonates at risk for necrotizing enterocolitis
US9227181B2 (en) 2011-09-13 2016-01-05 Basf Corporation Catalyst to increase propylene yields from a fluid catalytic cracking unit
EP2984114B1 (en) 2013-04-12 2017-03-15 Merck Patent GmbH Particles for electrophoretic displays
CN107108818B (zh) 2014-12-19 2021-01-01 默克专利股份有限公司 用于电泳显示器的颗粒
EP3508851A4 (en) * 2016-08-31 2020-07-29 Sekisui Chemical Co., Ltd. FLUORESCENT PARTICLES FOR A DIAGNOSIS AGENT AND IMMUNOLOGICAL ASSAY REAGENT USER
US12436080B2 (en) 2020-02-24 2025-10-07 Corning Incorporated Calibration set including nanoparticles of nylon-6 and dyes
CN111363539A (zh) * 2020-04-30 2020-07-03 上海思滤科技有限公司 一种单分散多色发光微球及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US5073497A (en) * 1989-06-30 1991-12-17 Caribbean Microparticles Corporation Microbead reference standard and method of adjusting a flow cytometer to obtain reproducible results using the microbeads
DE3850981T2 (de) * 1987-02-27 1995-03-30 Eastman Kodak Co Wasserunlösliches Teilchen und immunoreaktives Reagens, analytische Elemente und Verfahren zu ihrer Verwendung.
US5607864A (en) * 1992-04-07 1997-03-04 Societe Prolabo Fluorescent latices having very low detection thresholds for fluorescent emission
US5264960A (en) * 1992-05-08 1993-11-23 At&T Bell Laboratories Optical wavelength shifter
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5393527A (en) * 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation

Also Published As

Publication number Publication date
CA2167072C (fr) 2008-10-28
FR2707658A1 (fr) 1995-01-20
DE69403663T2 (de) 1998-01-02
EP0712426A1 (fr) 1996-05-22
DE69403663D1 (de) 1997-07-10
DK0712426T3 (da) 1997-12-22
CA2167072A1 (fr) 1995-01-26
FR2707658B1 (fr) 1995-11-24
WO1995002635A1 (fr) 1995-01-26
US5716855A (en) 1998-02-10
NO960123L (no) 1996-03-12
ES2104405T3 (es) 1997-10-01
NO308253B1 (no) 2000-08-21
JPH09504041A (ja) 1997-04-22
EP0712426B1 (fr) 1997-06-04

Similar Documents

Publication Publication Date Title
NO960123D0 (no) Fluorescerende lateks inneholdende to fluorkrom, fremgangsmåte for fremstilling av den og anvendelse av denne
US5657255C1 (en) Hierarchic biological modelling system and method
ES2094113T3 (es) Dna que codifica cd40.
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2065303T5 (es) Procedimiento de diagnosis y vacuna especifica.
DE69231644D1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
ATE360715T1 (de) Faser oder filament
AU6767090A (en) Process for the optical distinction of a dental material and dental material for said process
DE69403319D1 (de) Strahlungsinduzierte fixierung von farbstoffen
ATE67094T1 (de) Knochenzement.
DE3866072D1 (de) Pestizide biosynthetische produkte enthaltende zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung.
ES2084687T3 (es) Benzonitrilos substituidos.
ES2057638T3 (es) Composiciones insecticidas a base de bacillus thuringiensis.
DE69432124D1 (de) Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes
IT8022361A0 (it) Fosforo alluminato emettitore di raggi ultravioletti e lampade fluorescenti per l'abbronzatura artificiale utilizzanti tale fosforo.
ES2162078T3 (es) Compuestos terapeuticos.
JPS524200A (en) Fluorescence eye catcher sigh-board by stimulation of ultra-violet ray s
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ES2093135T3 (es) Anticuerpos monoclonales contra el complejo plasmina-antiplasmina, procedimiento para su preparacion asi como su utilizacion.

Legal Events

Date Code Title Description
MK1K Patent expired